In situ analyses of genome instability in breast cancer

Nature Genetics

Volumn 36, Issue 9, 2004, Pages 984-988

  Chin, Koei ^a   De Solorzano, Carlos Ortiz ^b   Knowles, David ^b   Jones, Arthur ^b   Chou, William ^b   Rodriguez, Enrique Garcia ^b   Kuo, Wen Lin ^a   Ljung, Britt Marie ^a   Chew, Karen ^a   Myambol, Kenneth ^a   Miranda, Monica ^a   Krig, Sheryl ^b   Garbe, James ^b   Stampfer, Martha ^b   Yaswen, Paul ^b   Gray, Joe W ^a,b   Lockett, Stephen J ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DUCT; BREAST DUCT HYPERPLASIA; BREAST EPITHELIUM; CARCINOMA IN SITU; CELL CULTURE; CELL IMMORTALIZATION; CLINICAL ARTICLE; DUCTAL CARCINOMA IN SITU; EPITHELIUM; EPITHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENETIC STABILITY; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IN VITRO STUDY; INTRADUCTAL CARCINOMA; MODEL; PRIORITY JOURNAL; TELOMERE; TELOMERE CRISIS; TUMOR GROWTH; ZNF217 GENE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHROMOSOMAL INSTABILITY; DISEASE PROGRESSION; HUMANS; HYPERPLASIA; IN SITU HYBRIDIZATION; TELOMERE; TUMOR CELLS, CULTURED;

EID: 4444345401     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1409     Document Type: Article

References (30)

1. Maser, R.S. & DePinho, R.A. Connecting chromosomes, crisis, and cancer. Science 297, 565-569 (2002).
2. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57-70 (2000).
3. Holst, C.R. et al. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63, 1596-1601 (2003).
4. Smogorzewska, A. & de Lange, T. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73, 177-208 (2004).
5. Romanov, S.R. et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409, 633-637 (2001).
6. Artandi, S.E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645 (2000).
7. Rudolph, K.L., Millard, M., Bosenberg, M.W. & DePinho, R.A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28, 155-159 (2001).
8. O'Hagan, R.C. et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2, 149-155 (2002).
9. O'Connell, P. et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J. Natl. Cancer Inst. 90, 697-703 (1998).
10. Meeker, A.K. et al. Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am. J. Pathol. 164, 925-935 (2004).
11. Herbert, B.S., Wright, W.E. & Shay, J.W. Telomerase and breast cancer. Breast Cancer Res. 3, 146-149 (2001).
12. Nonet, G. H. et al, The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res. 61, 1250-1254 (2001).
13. Thompson, C.T., LeBoit, P.E., Nederlof, P.M. & Gray, J.W. Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. Am. J. Pathol. 144, 237-243 (1994).
14. Isola, J.J. et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am. J. Pathol. 147, 905-911 (1995).
15. Waldman, F.M. et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J. Natl. Cancer Inst. 92, 313-320 (2000).
16. Knuutila, S., Autio, K. & Aalto, Y. Online access to CGH data of DNA sequence copy number changes. Am. J. Pathol. 157, 689 (2000).
17. Dupont, W.D. & Page, D.L. Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med. 312, 146-151 (1985).
18. Smalley, M. & Ashworth, A. Stem cells and breast cancer: A field in transit. Nat. Rev. Cancer 3, 832-844 (2003).
19. Takimoto, R. et al. The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein. Cancer Biol. Ther. 1, 47-55 (2002).
20. Kelland, L.R. Telomerase: biology and phase I trials. Lancet Oncol. 2, 95-102 (2001).
21. Kim, M.M. et al. A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation. Proc. Natl. Acad. Sci. USA 98, 7982-7987 (2001).
22. Ortiz de Solorzano, C. et al. Segmentation of confocal microscope images of cell nuclei in thick tissue sections. J. Microsc. 193, 212-226 (1999).
23. Snijders, A.M. et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29, 263-264 (2001).
24. Jain, A.N. et al. Fully automatic quantification of microarray image data. Genome Res. 12, 325-332 (2002).
25. Kallioniemi, O.P. et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA 89, 5321-5325 (1992).
26. Allsopp, R.C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10114-10118 (1992).
27. Nishizaki, T. et al. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 19, 267-272 (1997).
28. Kuukasjarvi, T. et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 57, 1597-1604 (1997).
29. Kuukasjarvi, T. et al. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Am. J. Pathol. 150, 1465-1471 (1997).
30. Yashima, K. et al. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin. Cancer Res. 4, 229-234 (1998).